Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 3, Number 10, October 2005

Favourites:
ADD

Free Content The discovery of TAFI
pp. 2139-2146(8)
Authors: NESHEIM, M.; BAJZAR, L.

Favourites:
ADD

Free Content PPAR agonists: a new strategy for antithrombotic therapy
pp. 2147-2148(2)
Authors: SMYTH, S. S.; JENNINGS, J. L.

Favourites:
ADD

Free Content Pioglitazone protects against thrombosis in a mouse model of obesity and insulin resistance
pp. 2149-2153(5)
Authors: BODARY, P. F.; VARGAS, F. B.; KING, S. A. D.; JONGEWARD, K. L.; WICKENHEISER, K. J.; EITZMAN, D. T.

Favourites:
ADD

Free Content An ideal thrombolytic and antithrombotic agent?
pp. 2154-2155(2)
Author: MATSUO, O.

Favourites:
ADD

Free Content A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity – a staphylokinase variant. I. In vitro study
pp. 2156-2165(10)
Authors: SZEMRAJ, J.; WALKOWIAK, B.; KAWECKA, I.; JANISZEWSKA, G.; BUCZKO, W.; BARTKOWIAK, J.; CHABIELSKA, E.

Favourites:
ADD

Free Content Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparin
pp. 2168-2175(8)
Authors: PRECHEL, M. M.; MCDONALD, M. K.; JESKE, W. P.; MESSMORE, H. L.; WALENGA, J. M.

Favourites:
ADD
Favourites:
ADD

Free Content Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case–control ‘NOHA first’ study
pp. 2178-2184(7)
Authors: LISSALDE-LAVIGNE, G.; FABBRO-PERAY, P.; COCHERY-NOUVELLON, E.; MERCIER, E.; RIPART-NEVEU, S.; BALDUCCHI, J.-P; DAURÈS, J.-P.; PERNEGER, T.; QUÉRÉ, I.; DAUZAT, M.; MARÈS, P.; GRIS, J.-C

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Free Content High functional levels of thrombin-activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic stroke
pp. 2211-2218(8)
Authors: LEEBEEK, F. W. G.; GOOR, M. P. J.; GUIMARAES, A. H. C.; BROUWERS, G.-J.; MAAT, M. P. M.; DIPPEL, D. W. J.; RIJKEN, D. C.

Favourites:
ADD

Free Content Pharmacokinetic studies on Wilfactin®, a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods
pp. 2219-2227(9)
Authors: GOUDEMAND, J.; SCHARRER, I.; BERNTORP, E.; LEE, C. A.; BOREL-DERLON, A.; STIELTJES, N.; CARON, C.; SCHERRMANN, J. M.; BRIDEY, F.; TELLIER, Z.; FEDERICI, A. B.; MANNUCCI, P. M.

Favourites:
ADD

Free Content Cysteine-mutations in von Willebrand factor associated with increased clearance
pp. 2228-2237(10)
Authors: SCHOOTEN, C. J.; TJERNBERG, P.; WESTEIN, E.; TERRAUBE, V.; CASTAMAN, G.; MOURIK, J. A.; HOLLESTELLE, M. J.; VOS, H. L.; BERTINA, R. M.; BERG, H. M.; EIKENBOOM, J. C. J.; LENTING, P. J.; DENIS, C. V.

Favourites:
ADD

Free Content Modeling premature occurrence of acute coronary syndrome with atherogenic and thrombogenic risk factors and gene markers in extended families
pp. 2238-2244(7)
Authors: GRASSI, M.; ASSANELLI, D.; MOZZINI, C.; ALBERTINI, F.; SALVADORI, G.; ARCHETTI, S.; NEGRINI, R.; GALEAZZI, G.; PEZZINI, A.

Favourites:
ADD
Favourites:
ADD

Free Content Protein Z plasma levels in different phases of activity of coronary atherosclerosis
pp. 2254-2258(5)
Authors: SOFI, F.; CESARI, F.; VIGIANI, S.; FATINI, C.; MARCUCCI, R.; GIGLIOLI, C.; VALENTE, S.; ABBATE, R.; GENSINI, G. F.; FEDI, S.

Favourites:
ADD
Favourites:
ADD

Free Content Factor VIIa binding and internalization in hepatocytes
pp. 2264-2273(10)
Authors: HJORTOE, G.; SORENSEN, B. B.; PETERSEN, L. C.; RAO, L. V. M.

Favourites:
ADD

Free Content Extra-hepatic factor VIII expression in porcine fulminant hepatic failure
pp. 2274-2280(7)
Authors: HOLLESTELLE, M. J.; POYCK, P. P. C.; HOLLESTELLE, J. M.; MARSMAN, H. A.; MOURIK, J. A.; GULIK, T. M.

Favourites:
ADD

Free Content Apo(a) promotes thrombosis in a vascular injury model by a mechanism independent of plasminogen
pp. 2281-2289(9)
Authors: SHA, J.; MCCULLOUGH, B.; HART, E.; NASSIR, F.; DAVIDSON, N. O.; HOOVER-PLOW, J.

Favourites:
ADD

Free Content Thrombotic phenotype of mice with a combined deficiency in plasminogen activator inhibitor 1 and vitronectin
pp. 2290-2295(6)
Authors: KOSCHNICK, S.; KONSTANTINIDES, S.; SCHÄFER, K.; CRAIN, K.; LOSKUTOFF, D. J.

Favourites:
ADD

Free Content A differential role of the platelet ADP receptors P2Y1 and P2Y12 in Rac activation
pp. 2296-2306(11)
Authors: SOULET, C.; HECHLER, B.; GRATACAP, M.-P.; PLANTAVID, M.; OFFERMANNS, S.; GACHET, C.; PAYRASTRE, B.

Favourites:
ADD

Free Content Association of the antagonism of von Willebrand factor but not fibrinogen by platelet αIIbβ3 antagonists with prolongation of bleeding time
pp. 2307-2314(8)
Authors: AOKI, T.; TOMIYAMA, Y.; HONDA, S.; MIHARA, K.; YAMANAKA, T.; OKUBO, M.; MORIGUCHI, A.; MUTOH, S.

Favourites:
ADD

Free Content Impaired platelet function in a patient with P2Y12 deficiency caused by a mutation in the translation initiation codon
pp. 2315-2323(9)
Authors: SHIRAGA, M.; MIYATA, S.; KATO, H.; KASHIWAGI, H.; HONDA, S.; KURATA, Y.; TOMIYAMA, Y.; KANAKURA, Y.

Favourites:
ADD

Free Content Highly constrained cyclic (S,S) -CXaaC- peptides as inhibitors of fibrinogen binding to platelets
pp. 2324-2330(7)
Authors: KOUKI, A.; MITSIOS, J. V.; SAKARELLOS-DAITSIOTIS, M.; SAKARELLOS, C.; TSELEPIS, A. D.; TSIKARIS, V.; TSOUKATOS, D. C.

Favourites:
ADD

Free Content Adenine nucleotide metabolism in human blood – important roles for leukocytes and erythrocytes
pp. 2331-2339(9)
Authors: HEPTINSTALL, S.; JOHNSON, A.; GLENN, J. R.; WHITE, A. E.

Favourites:
ADD

Free Content Cyclooxygenase-1 haplotype modulates platelet response to aspirin
pp. 2340-2345(6)
Authors: MAREE, A. O.; CURTIN, R. J.; CHUBB, A.; DOLAN, C.; COX, D.; O'BRIEN, J.; CREAN, P.; SHIELDS, D. C.; FITZGERALD, D. J.

Favourites:
ADD

Free Content Red blood cell transfusion in patients with type 1 Glanzmann's thrombasthenia
pp. 2346-2347(2)
Authors: LAURIAN, Y.; TISSERON-MAURY, B.; BIBI TRIKI, T.; KAPLAN, C.; GAUDELUS, J.

Favourites:
ADD

Free Content Four cases of hypofibrinogenemia associated with four novel mutations
pp. 2347-2349(3)
Authors: HANSS, M.; FFRENCH, P.; VINCIGUERRA, C.; BERTRAND, M.-A; MAZANCOURT, P.

Favourites:
ADD

Free Content P2Y1 gene polymorphism and ADP-induced platelet response
pp. 2349-2350(2)
Authors: FONTANA, P.; REMONES, V.; RENY, J.-L.; AIACH, M.; GAUSSEM, P.

Favourites:
ADD

Free Content Inhibition of thrombin activatable fibrinolysis inhibitor augments fibrinolysis in human whole blood
pp. 2351-2353(3)
Authors: CRUDEN, N. L. M.; LAWES, L.; MASSON, P.; ROBINSON, S. D.; LUDLAM, C. A.; NEWBY, D. E.

Favourites:
ADD

Free Content Fast kinetic assay for the determination of procarboxypeptidase U (TAFI) in human plasma
pp. 2353-2355(3)
Authors: WILLEMSE, J. L.; LEURS, J. R.; HENDRIKS, D. F.

Favourites:
ADD
Favourites:
ADD

Free Content Characterization of a novel prothrombin variant, Prothrombin C20209T, as a modifier of thrombotic risk among African-Americans
pp. 2357-2359(3)
Authors: ITAKURA, H.; TELEN, M. J.; HOPPE, C. C.; WHITE, D. A. E.; ZEHNDER, J. L.

Favourites:
ADD

Free Content Performances of the HemosIL D-dimer HS assay for the exclusion of venous thromboembolism
pp. 2361-2363(3)
Authors: MOERLOOSE, P.; VANRUSSELT, M.; REBER, G.; ARNOUT, J.

Favourites:
ADD

Free Content Graduated compression stockings for the prevention of venous thromboembolism in surgical patients in the age of low molecular weight heparins
pp. 2363-2365(3)
Authors: SCHULZ, S. L.; STECHEMESSER, B.; SEEBERGER, U.; MEYER, D.; KESSELRING, C.

Favourites:
ADD
Favourites:
ADD

Free Content More on: intensity of warfarin anticoagulation in APS
pp. 2368-2369(2)
Author: KEY, N. S.

Favourites:
ADD

Free Content Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination – a rebuttal
pp. 2370-2371(2)
Authors: EGBERG, N.; FAGERBERG, I.; HILLARP, A.; LINDAHL, T. L.; STIGENDAL, L.

Favourites:
ADD

Free Content Talking about…
pp. 2373-2375(3)
Authors: BRUTTOMESSO, G.; MIGLINO, N.

Favourites:
ADD

Free Content Note to Readers
pp. 2376-2376(1)

Favourites:
ADD

Free Content Announcements
pp. 2377-2377(1)

Favourites:
ADD

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more